東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Diagnosis and management of testicul...

Krege, Susanne.

FindBook

Google Book

Amazon

博客來

Diagnosis and management of testicular cancer = the European point of view /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Diagnosis and management of testicular cancer/ edited by Susanne Krege.
其他題名:	the European point of view /
其他作者:	Krege, Susanne.
出版者:	Cham :Springer International Publishing : : 2015.,
面頁冊數:	viii, 135 p. :ill., digital ;24 cm.
內容註:	Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility.
Contained By:	Springer eBooks
標題:	Testis - Cancer -
電子資源:	http://dx.doi.org/10.1007/978-3-319-17467-9
ISBN:	9783319174679 (electronic bk.)

Diagnosis and management of testicular cancer = the European point of view /
Diagnosis and management of testicular cancerthe European point of view /[electronic resource] :edited by Susanne Krege. - Cham :Springer International Publishing :2015. - viii, 135 p. :ill., digital ;24 cm.

Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility.

This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.

ISBN: 9783319174679 (electronic bk.)

Standard No.: 10.1007/978-3-319-17467-9doiSubjects--Topical Terms:

2153602
Testis
--Cancer

LC Class. No.: RC280.T4

Dewey Class. No.: 616.99463

Diagnosis and management of testicular cancer = the European point of view /
LDR:03339nmm a2200313 a 4500 001 2006576
003 DE-He213
005 20160108113237.0
006 m d
007 cr nn 008maaau
008 160114s2015 gw s 0 eng d
020 $a 9783319174679 (electronic bk.)
020 $a 9783319174662 (paper)
024 7 $a 10.1007/978-3-319-17467-9 $2 doi
035 $a 978-3-319-17467-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.T4
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99463 $2 23
090 $a RC280.T4 $b D536 2015
245 0 0 $a Diagnosis and management of testicular cancer $h [electronic resource] : $b the European point of view / $c edited by Susanne Krege.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a viii, 135 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part I: Overview of the latest recommendations of the European Germ Cell Cancer Group -- Part II: Special topics about controversial aspects, new results from studies, which might change treatment recommendations and long-term-survivorship: Is there still an indication for radiotherapy in seminoma CS I/ IIA/B?- How should we treat nonseminoma CSI? -- Is there still an indication for diagnostic RPLND in nonseminoma CSI? -- How could the prognosis of patients with intermediate risk disease be improved? -- How should patients with poor-prognosis disease be treated actually? -- How should patients with recurrent disease be treated actually? -- How important are prognostic factors for determining treatment in patients with primary or recurrent disease? -- What should be the boundaries in retroperitoneal residual tumor resection in nonseminoma? -- How should residual disease outside the retroperitoneum be treated? -- What are the recent recommendations for follow up in testicular cancer? -- What are the long-term toxicities to be controlled and treated? -- Consequences of the disease and its treatment concerning sexuality and fertility.
520 $a This book presents the views of leading European experts on the diagnosis and management of testicular cancer, with coverage of current hot topics in the field. It opens by providing an overview of the recommendations in the most recent consensus paper from the European Germ Cell Cancer Consensus Group, which is based on interdisciplinary cooperation among urologists, medical oncologists, radio-oncologists, pathologists, and basic scientists. The remainder of the book focuses on areas of controversy in the diagnosis, treatment, and follow-up of testicular cancer. In each case the evidence base is discussed and results from the most recent studies are reviewed, drawing attention to new findings that might alter treatment recommendations. The treatment-related chapters cover a broad range of issues, including the best approach in patients with poor-prognosis and recurrent disease and those with long-term toxicities. Relevant aspects of survivorship care are also addressed. The book will help clinicians and practitioners to achieve the goals of minimizing therapy and its side-effects without reducing efficacy in low stage disease, improving the cure rate in advanced disease, and enhancing follow-up and long-term survivorship.
650 0 $a Testis $x Cancer $x Diagnosis. $3 2153602
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Oncology. $3 751006
650 2 4 $a Urology. $3 636586
650 2 4 $a Surgery. $3 707153
650 2 4 $a Radiotherapy. $3 862372
700 1 $a Krege, Susanne. $3 2153601
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-17467-9
950 $a Medicine (Springer-11650)